These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

911 related articles for article (PubMed ID: 12280213)

  • 21. Triphasics: have they fulfilled their promise?
    Weisberg E
    Curr Ther (Seaforth); 1992 Jan; 33(1):11-6. PubMed ID: 12286973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Oral contraception with Moneva: findings of a cohort study of 6000 women].
    Szapiro N
    C R Ther Pharmacol Clin; 1993; (112):3-7. PubMed ID: 12318672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post coital contraception.
    Haspels AA; Van Santen MR
    J Gynaecol Endocrinol; 1986; 2(1-2):17-24. PubMed ID: 12269214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Macroprogestative contraception: advantages].
    Jamin C
    Contracept Fertil Sex (Paris); 1993 Feb; 21(2):123-8. PubMed ID: 12318009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duration of lactation and return of menstruation in lactating women using hormonal contraception and IUDs.
    Prema K
    Contracept Deliv Syst; 1982 Jan; 3(1):39-46. PubMed ID: 12264126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fertility and characteristics of ovulation after discontinuing oral contraception].
    Gaspard U; Lambotte R
    Contracept Fertil Sex (Paris); 1984 Sep; 12(9):1005-10. PubMed ID: 12266509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New 2-step minidosage estro-progestagen contraceptive pill].
    Soutoul JH; Renaud M; Bertrand J
    Sem Hop Paris; 1977 Jan; 53(1):39-45. PubMed ID: 12260758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Contraception for the diabetic woman].
    Arlot S; Mesmacque A; Lalau JD; Quichaud J
    Fertil Contracept Sex; 1988 Nov; 16(11):921-6. PubMed ID: 12282829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acceptability study of the two versus three monthly injectable contraceptives.
    Aly FA; El-genedi MM; Toppozada HK; El-abd M; Loutfi I
    Dirasat Sukkaniyah; 1984; 11(69):27-39. PubMed ID: 12179796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Oral contraception: evolution of concepts over the last thirty years].
    Belaisch J; Hommais-loufrani B
    Contracept Fertil Sex (Paris); 1987 Nov; 15(11 Suppl):1-8. PubMed ID: 12281408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Oral contraception: failures and risks].
    Foussard-blanpin O; Paillot-renaud P; Bruneau-bigot A
    Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The present state of research on the relationship of oral contraceptives to breast cancer].
    Pike MC
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):329-38. PubMed ID: 12280203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Veins and contraception].
    Reinharez D; Monsonego J
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):131-6. PubMed ID: 12280199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gestodene: clinical experience with an innovative progestogen used in a combination oral contraceptive preparation.
    Merchiers E; Thiery M; Van Kets H; Parewijck W; Defoort P; Martens G
    Acta Ther; 1990; 16(2):129-38. PubMed ID: 12342969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Metabolic risks of oral contraception].
    Monier L
    Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women.
    Gaspard UJ; Deville JL; Dubois M
    Curr Med Res Opin; 1983; 8(6):395-404. PubMed ID: 6406157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effectiveness and safety of a new combined oral contraceptive containing 75 micrograms gestodene and 30 micrograms ethinyl estradiol in Mexican women].
    Martinez M; Perez Palacios G; Garza Flores J; Bassol S; Recio R
    Invest Med Int; 1990; 17(1):3-9. PubMed ID: 12283863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oral contraceptives and blood platelets].
    Davenas E; Ciavatti M; Poitevin B; Aubin M
    Homeopath Fr; 1985; 73(5):299-305. PubMed ID: 12281246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Contraception for women over 40].
    Erny R; Mathet M
    Contracept Fertil Sex (Paris); 1984 Dec; 12(12):1323-34. PubMed ID: 12266611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.